Latest News

Glenmark Pharmaceuticals Q2 PAT plunges 57% to Rs. 264 crore amid North American slump; India sales grow 14%

The company's consolidated total revenue from operations for the July–September quarter fell 29.8% to Rs. 4,247.32 crore

SMS Pharma Q2 PAT jumps 57% to Rs 40 crore as revenue surges 30%

Its Rs 280 crore capital expenditure programme remains on track for completion by FY27, with Rs 160 crore already deployed

Hester Biosciences Q2 net profit jumps 44% to Rs 20.63 crore; revenue surges 38%

Operating performance also strengthened significantly, with consolidated EBITDA climbing 55% year-on-year to Rs 36.52 crore

Moderna Ebola vaccine candidate set to advance to Phase 2/3 trial in DR Congo

The recommendation was made after the World Health Organization's Technical Advisory Group on Candidate Vaccine Prioritization (TAG-CVP) reviewed the available evidence

HRV Pharma acquires German firm Phatebo to enter European finished formulations market

The company has signed definitive agreements to acquire 100 per cent of Phatebo’s equity from ZeroStack Corp

Ennature Bio Pharma lists on NSE & BSE as it bets big on science-backed nutraceuticals

The biopharma division of IGL reported net revenue of Rs 246 crore, EBITDA of Rs 29 crore and a gross margin of 40.1% in FY26

Emcure Pharmaceuticals posts 24% revenue growth in Q2 FY27; profit jumps 29%

International operations emerged as the biggest growth driver, posting a 34.5% increase in revenue to Rs 16,652 million

Fresenius strikes landmark WuXi Biologics deal to nearly triple biosimilar pipeline to 66 molecules

Under the deal, Fresenius will retain exclusive global commercialization rights, including marketing authorizations

FDA places Bright Minds Biosciences’ Phase 2 epilepsy trial on partial clinical hold over mouse toxicity concerns

The decision affects the planned US Phase 2 trial of BMB-101 in patients with DEEs

Beauty & beyond: BASF unveils breakthrough ingredient for post-laser skin recovery

Clinical results suggest significant potential

Ichnos Glenmark Innovation to present updated ISB 2001 aata at 68th ASH meeting

Updated Phase 1 TRIgnite-1 data includes longer follow-up and early dose-expansion results for heavily pretreated multiple myeloma patients

Dabur reports 11. 7% growth in Q2 PAT at Rs. 505 Cr

India FMCG business grows 10.7%; International business grows 20%

Indian Pharma Post is an online platform that provides news and insights on the pharmaceutical industry. It reports on the latest news updates, drug discoveries, and research reports. It highlights trending topics in the entire healthcare universe and will lay emphasis on the new best practices across the spectrum of the industry. It hosts a team of experts who will provide insights on policies that shape developments in the industry.